REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,616,434 | -77.2% | 84,508 | -79.6% | 0.02% | -78.8% |
| Q1 2023 | $37,727,619 | +383.6% | 414,954 | +102.1% | 0.08% | +344.4% |
| Q4 2022 | $7,800,945 | +2483.1% | 205,342 | +1611.2% | 0.02% | +1700.0% |
| Q3 2022 | $302,000 | -76.8% | 12,000 | +14.1% | 0.00% | -85.7% |
| Q4 2020 | $1,300,000 | +92.6% | 10,516 | +51.9% | 0.01% | +75.0% |
| Q3 2020 | $675,000 | +211.1% | 6,925 | -34.7% | 0.00% | -55.6% |
| Q1 2018 | $217,000 | – | 10,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |